The prevention of adverse pregnancy outcomes by periodontal treatment during pregnancy (PROBE) intervention study-A controlled intervention study: Protocol paper.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 04 01 2024
accepted: 21 03 2024
medline: 13 5 2024
pubmed: 13 5 2024
entrez: 13 5 2024
Statut: epublish

Résumé

Pregnancy increases the risk of periodontitis due to the increase in progesterone and estrogen. Moreover, periodontitis during pregnancy is associated with development of pregnancy and birth related complications. The aim of this study is to determine, whether periodontal treatment during pregnancy can reduce systemic inflammation and lower the risk of adverse pregnancy and birth related outcomes. The PROBE study is a non-randomized controlled intervention study conducted among 600 pregnant women with periodontitis. The women will be recruited among all pregnant women at two Danish hospitals in Region Zealand during their nuchal translucency scan and will subsequently be screened for periodontitis. The intervention group includes 300 pregnant women, who will be offered state-of-the-art periodontal treatment during pregnancy. The control group includes additional 300 pregnant women, who will be offered periodontal treatment after giving birth. Outcome measures include periodontal measures, inflammatory, hormonal and glycaemic markers as well as the prevalence of preterm birth risk, low birth weight and risk markers of gestational diabetes mellitus (GDM) and preeclampsia that will be collected from all screened women and further during pregnancy week 20 and pregnancy week 35 for women enrolled in the intervention. The study's findings will be published in peer reviewed journals and disseminated at national and international conferences and through social media. The PROBE study is designed to provide important new knowledge as to whether periodontal treatment during pregnancy can reduce the prevalence of complications related to pregnancy and birth. The study was registered on clinicaltrials.gov (NCT06110143).

Identifiants

pubmed: 38739615
doi: 10.1371/journal.pone.0302010
pii: PONE-D-23-40210
doi:

Banques de données

ClinicalTrials.gov
['NCT06110143']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0302010

Informations de copyright

Copyright: © 2024 Winckler et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Karoline Winckler (K)

The Research Unit for Dietary Studies, The Parker Institute, Copenhagen University Hospital, Copenhagen, Denmark.

Kathrine Hansen Bukkehave (KH)

The Research Unit for Dietary Studies, The Parker Institute, Copenhagen University Hospital, Copenhagen, Denmark.

Lise Tarnow (L)

Steno Diabetes Center Sjælland, Herlev, Denmark.

Peter Bindslev Iversen (PB)

Steno Diabetes Center Sjælland, Herlev, Denmark.

Christian Damgaard (C)

Department of Odontology, Section for Oral Biology and Immunopathology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Sisse Bolm Ditlev (SB)

Copenhagen Center for Translational Research, Bispebjerg-Frederiksberg University Hospital, Copenhagen, Denmark.

Allan Kofoed-Enevoldsen (A)

Department of Endocrinology, Nykoebing Falster Hospital, Nykøbing Falster, Denmark.

Heidi Marianne Fischer (HM)

Department of Obstetrics and Gynecology, Holbaek Hospital, Holbæk, Denmark.

Signe Camilla Hjuler Dueholm (SCH)

Department of Obstetrics and Gynecology, Holbaek Hospital, Holbæk, Denmark.

Jeannet Lauenborg (J)

Department of Obstetrics and Gynecology, Copenhagen University Hospital Herlev, Herlev, Denmark.

Cæcilie Trier (C)

Department of Obstetrics and Gynecology, Nykoebing Falster Hospital, Nykøbing Falster, Denmark.

Berit Lilienthal Heitmann (BL)

The Research Unit for Dietary Studies, The Parker Institute, Copenhagen University Hospital, Copenhagen, Denmark.
The Boden Group, Charles Perkins Centre, University of Sydney, Camperdown, Australia.
Department of Public Health, Section for General Practice, University of Copenhagen, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH